ABSTRACT. Vibrio vulnificus is known as an opportunistic bacterial pathogen that causes primary septicemia and wound infection in humans. Recently, the incidence of wound infection by V. vulnificus is increasing in warm countries. In this study, we examined a vaccine antigen against V. vulnificus in mice. FlaB, a component protein of the V. vulnificus flagellum, was expressed as a recombinant protein, named rFlaB. After immunization of mice with rFlaB, the mice were challenged by subcutaneous inoculation with V. vulnificus. Bacterial burdens in muscular tissue at the infection site in rFlaB-immunized mice were significantly decreased compared with those of control mice. We found that rFlaB immunization can partially suppress proliferation of V. vulnificus at the local infection site.
secondary antibodies. Western blotting showed that the rFlaB-immunized mice sera contained antibodies against FlaB and sonicated V. vulnificus (Fig. 1A) . Only one band appeared against the rFlaB, whereas two bands appeared against sonicated V. vulnificus (Fig. 1A) . These results indicate that the antibody against rFlaB was able to bind the other flagellin, such as FlaA, -C, -D, -E and -F, that show 51 to 99% sequence identities with FlaB (data not shown). Indeed, it was reported that four flagellin proteins could be detected as the three bands in the isolated flagellin fraction from V. vulnificus CMCP6 in western blot analysis using a mixture of six flagellin (FlaA,-B, -C, -D, -E and -F) antibodies [9] . Detailed results of detected flagellin bands in this previous report showed that FlaC was the highest molecular weight, however the FlaC band was recognized as an almost single band together with the next lower single band, which included the FlaB/-D [9] . In addition to these two bands (FlaC and FlaB/-D), FlaA appeared as the lowest band [9] . Based on these previous reports, bands detected by the rFlaB-immunized mice sera in this study would include FlaB/-D, and -C (black arrowhead) and FlaA (white arrowhead) (Fig. 1A) . Thus, the rFlaB-immunized mice sera could recognize at least two or three flagellin proteins of V. vulnificus.
To determine the antibody response in the rFlaB-immunized mice, anti-rFlaB antibody titers were determined by Enzyme-linked immunosorbent assay (ELISA) using the 3,3,5,5′-tetramethyl benzidine liquid substrate system (Sigma-Aldrich, Tokyo, Japan). We used Mann-Whitney's U-test to compare the differences between the two groups, and a P value less than 0.05 was considered statistically significant. The specific antibody titer for flagellin protein was significantly higher in the rFlaB-immunized mice sera than in the control mice (Fig. 1B) .
To investigate whether or not immunization with purified rFlaB can prevent the wound infection, the control and rFlaBimmunized mice were s.c. inoculated with 1. 1 × 10 7 colony-forming units (CFU)/mouse of V. vulnificus CMCP6. The infection mice were monitored for 72 hr, and sacrificed when they displayed critical symptoms that link with death directly by severe infection. Survivors were sacrificed at 72 hr post-infection. Muscle at the infection site and spleen of sacrificed mice were harvested immediately, homogenized in PBS containing 0.1% gelatin, and plated onto LB agar plates containing 50 µg/ml rifampicin and incubated for 12 hr at 37°C. To compare the differences in bacterial burdens of V. vulnificus in those tissues between the two groups, we used Mann-Whitney's U-test, and a P value less than 0.05 was considered statistically significant. In the muscular tissue, the median bacterial burden in the control mice was 3.02 × 10 8 CFU/g, whereas that in the rFlaB-immunized mice was significantly decreased to 1.78 × 10 8 CFU/g ( Fig. 2A) . However, there were no differences in bacterial burdens in the spleen (Fig. 2B) . These results indicate that immunization of rFlaB can partly prevent the proliferation of V. vulnificus in the muscular tissue. Survival times tended to be longer in the rFlaB-immunized mice compared with that of the control mice, but the two curves finally overlapped at 36 hr after inoculation with V. vulnificus (Fig. 3) .
Bacterial motility toward their favorable environment is accomplished by regulating the direction of flagellar rotation. Several studies have reported significantly reduced colonization in gastric mucosa by Helicobacter pylori mutants lacking flagellar-based motility or chemotaxis [17, 22] . It is also known that V. vulnificus are isolated from the necrotic lesion of muscular tissue both in wound infection and after ingestion of contaminated seafood. These facts strongly suggested that V. vulnificus has positive chemotaxis attracted toward muscular tissue for colonization and proliferation. Therefore, the rFlaB immunization would inhibit invasion of muscular tissue from subcutaneous tissue by decreasing the motility of V. vulnificus. From a different perspective, flagellar-based motility does not seem to be important after the invasion of the systemic circulation. This perspective is in agreement with a report that flagellar-based motility of Listeria monocytogenes is not important for the proliferation of this bacterium in systemic circulation [20] .
Regardless of the fact that the anti-flagellum antibody titer was elevated by rFlaB immunization, the overall effect of the rFlaB immunization was limited in our study. Improvement of this rFlaB vaccine will be needed in the future. Flagellin has already been found to have high adjuvant activity [19, 24] , and therefore should be combined with another additional antigen such as Vibrio vulnificus hemolysin VVH, metalloprotease VvpE, and/or RTX toxin [3, 10, 13, 14, 16] . There have been many reports on utilization of these proteins as vaccine antigens, and immunization with these proteins confers effective protection against lethal challenge by V. vulnificus on hosts [10] . In addition, immunization of an attenuated strain of V. vulnificus with triple deletion in VVH, VvpE, and RTX also provided efficient protection from challenge by a homologous strain [10] . However, in all of these previous reports, routes of infection with V. vulnificus after immunization did not assume wound infection such as s.c. inoculation into the thigh of mice. We need to attempt to combine some of the above antigens to develop a vaccine for wound infection caused by V. vulnificus in the future.
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